Literature DB >> 11217377

Purification and conjugation of type 1 ribosome-inactivating proteins.

L Barbieri1, A Bolognesi, F Stirpe.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11217377     DOI: 10.1385/1-59259-114-0:71

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


× No keyword cloud information.
  5 in total

1.  A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin.

Authors:  D Castelletti; G Fracasso; S Righetti; G Tridente; R Schnell; A Engert; M Colombatti
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

2.  Ribosomal RNA N-glycosylase Activity Assay of Ribosome-inactivating Proteins.

Authors:  Rosario Iglesias; Lucía Citores; José M Ferreras
Journal:  Bio Protoc       Date:  2017-03-20

Review 3.  Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.

Authors:  Shaowei Zhu; Yuanyi Liu; Paul C Wang; Xinbin Gu; Liang Shan
Journal:  Biomed Res Int       Date:  2017-06-29       Impact factor: 3.411

4.  Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells.

Authors:  Letizia Polito; Daniele Mercatelli; Massimo Bortolotti; Stefania Maiello; Alice Djemil; Maria Giulia Battelli; Andrea Bolognesi
Journal:  Toxins (Basel)       Date:  2017-05-30       Impact factor: 4.546

5.  High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin.

Authors:  Massimo Bortolotti; Andrea Bolognesi; Maria Giulia Battelli; Letizia Polito
Journal:  Toxins (Basel)       Date:  2016-06-21       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.